minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: rhabdomyosarcoma-clinical-group-stage-IA - JSON Representation

Raw json | Download

{
  "resourceType" : "Observation",
  "id" : "rhabdomyosarcoma-clinical-group-stage-IA",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-stage"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Observation rhabdomyosarcoma-clinical-group-stage-IA</b></p><a name=\"rhabdomyosarcoma-clinical-group-stage-IA\"> </a><a name=\"hcrhabdomyosarcoma-clinical-group-stage-IA\"> </a><a name=\"rhabdomyosarcoma-clinical-group-stage-IA-en-US\"> </a><p><b>status</b>: Final</p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}\">Laboratory</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 405916000}\">Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-john-anyperson.html\">John B. Anyperson  Male, DoB: 1951-01-20 ( Medical Record Number: m123\u00a0(use:\u00a0usual,\u00a0))</a></p><p><b>focus</b>: <a href=\"Condition-primary-cancer-condition-nonspecific.html\">Condition Metastatic malignant neoplasm (disorder)</a></p><p><b>effective</b>: 2021-04-01</p><p><b>performer</b>: <a href=\"Practitioner-us-core-practitioner-kyle-anydoc.html\">Practitioner Kyle Anydoc </a></p><p><b>value</b>: <span title=\"Codes:{http://snomed.info/sct 405957007}\">Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding)</span></p></div>"
  },
  "status" : "final",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/observation-category",
          "code" : "laboratory"
        }
      ]
    }
  ],
  "code" : {
    "coding" : [
      {
        "system" : "http://snomed.info/sct",
        "code" : "405916000",
        "display" : "Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/cancer-patient-john-anyperson"
  },
  "focus" : [
    {
      🔗 "reference" : "Condition/primary-cancer-condition-nonspecific"
    }
  ],
  "effectiveDateTime" : "2021-04-01",
  "performer" : [
    {
      🔗 "reference" : "Practitioner/us-core-practitioner-kyle-anydoc"
    }
  ],
  "valueCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://snomed.info/sct",
        "code" : "405957007",
        "display" : "Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding)"
      }
    ]
  }
}